The short answer
A variant of uncertain significance means the lab found a genetic difference and does not yet know whether it matters. It is not a positive result. Guidelines are clear that a VUS should not change your medical care, and most are eventually reclassified as harmless.
A VUS is not a positive result and not a diagnosis; it is a category for evidence that is still incomplete.
Clinical guidelines state a VUS should not be used in medical decision-making — it is not a reason for extra screening, medication, or surgery.
Your care should continue to follow your personal and family history, exactly as it would if the VUS had never been reported.
When variants are reclassified, roughly nine in ten are downgraded to benign and about one in ten upgraded to pathogenic.
Choose how you want to understand this
The full explanation.
What the result actually says
A variant of uncertain significance — usually written VUS — means the laboratory found a spelling difference in one of your genes and does not yet have enough evidence to say whether it matters.
It is not a diagnosis. It is not a weak positive, and it is not a mutation that has been shown to cause cancer. It is a filing category for evidence that is still incomplete.
Laboratories sort variants into five tiers under the framework published by the American College of Medical Genetics and Genomics: pathogenic, likely pathogenic, uncertain significance, likely benign, and benign. A VUS sits in the middle because the data available today does not push it either way.
The most important point: your care should not change
Clinical guidelines are consistent that a variant of uncertain significance should not be used to make medical decisions. A VUS is not a reason to add screening, start a medication, or have risk-reducing surgery.
Your screening and prevention plan should continue to be based on your personal history and your family history — the same things that would have guided it if the VUS had never been reported. If a VUS has been used to justify a change in your management, that is worth raising with a genetic counselor.
Most are eventually reclassified as benign
A VUS is a temporary label. As laboratories gather more data, from population databases, from laboratory studies of how the gene behaves, and from families where the variant either does or does not track with disease, variants get reclassified.
When reclassification happens, the direction is lopsided. In published series, roughly nine out of ten reclassified variants are downgraded to benign or likely benign, and around one in ten is upgraded. Reclassification can take months or many years.
The practical step: keep your contact details current with the clinic that ordered the test, so the laboratory can reach you if your variant is reclassified. Some clinics will re-request an interpretation on your behalf every few years if you ask.
Why VUS results are so common
Roughly one in five hereditary cancer panels returns at least one VUS, and the rate is higher on large panels covering dozens of genes. Testing more genes finds more rare spellings, most of which are ordinary human variation.
VUS results are also reported more often in people of African, Asian, Hispanic and other non-European ancestries. This is not a difference in biology. Reference databases were built largely from people of European ancestry, so there is less comparison data available for everyone else, and less data means more uncertainty. The gap is narrowing as databases broaden, but it is a real reason a VUS may appear on your report.
What this means for your relatives
Testing relatives for a VUS is generally not recommended. Because the variant's meaning is unknown, a relative's result would not clarify their risk or change their care. It would only spread the uncertainty.
There is one exception. A genetics team may ask several relatives, especially those who have had cancer, to be tested as part of research into whether the variant tracks with cancer in the family. That is done to help classify the variant, not to guide anyone's medical decisions, and it should be framed that way.
If your family history is strong, your relatives may still qualify for testing or increased screening on the strength of that history alone. The VUS neither adds to nor subtracts from it.
Living with an unresolved result
An uncertain result can sit uncomfortably. Some people describe feeling more anxious after a VUS than before testing, and it is common to search the report for meaning it does not contain.
It may help to hold two things at once: the uncertainty is real, and it is not currently actionable. What is actionable is the family history you already knew about.
Going through the report line by line with a genetic counselor — what the gene does, what the laboratory did and did not find, what would have to change for the classification to move — often settles it more than rereading the report.
Sources
Words to know
Tap any term to see what it means.
Common questions
Is a VUS a mild version of a positive result?
No. It sits in a separate category from pathogenic and likely pathogenic findings. Laboratories use five tiers under the American College of Medical Genetics and Genomics framework, and a VUS falls in the middle because the current evidence does not point either way. Treating it as a weak positive is the most common misunderstanding.
Should I have extra screening or risk-reducing surgery because of a VUS?
Not on the basis of the VUS itself. Guidelines are consistent that a variant of uncertain significance should not drive medical decisions. If your family history warrants extra screening, that screening is justified by the history, not by the variant.
Will I find out if my variant is reclassified?
Usually only if the clinic that ordered the test can still reach you. Keep your contact details current with that clinic. Some centers will also re-request an updated interpretation from the laboratory every few years if you ask them to.
Should my sister or my children be tested for my VUS?
Generally no. Their result would not clarify their cancer risk or change their care. A genetics team may sometimes test several relatives who have had cancer as part of research into classifying the variant, but that is done to help science, not to guide anyone's treatment, and it should be explained as such.
Why did I get a VUS when my friend got a clear answer?
Larger panels test more genes and therefore find more rare spellings, most of which are harmless. Around one in five hereditary cancer panels returns at least one VUS. The number of genes tested, and how much reference data exists for people of your ancestry, both affect the odds.
Questions to ask your doctor
Being prepared helps you get the most out of your appointments. Save or print these questions.
Tap a question to save it to your list (kept on this device).
Speak With Trained Specialists & Human Navigators
Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.
Talk to a trained cancer information specialist
Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.
Contact your oncology team
Locate after-hours contact numbers, portal messages, or urgent triage phone lines.
Find a patient navigator
Get one-on-one help with appointments, logistics, translation, and care coordination.
Find a genetic counselor
Discuss inherited mutation risk, family history, and genetic testing options.
Find an oncology social worker
Access emotional counseling, family support groups, and mental health resources.
Find a financial navigator
Locate copay assistance foundations, grant programs, and lodging/travel support.
Find a clinical-trial specialist
Search matching studies and speak with NCI trial information specialists.
Get urgent help
Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.
Help Us Improve This Guide
Did this explanation answer your question and help you determine your next step?
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Plain-language explanation of the federal sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.
Written by: Cancer Explained Editorial TeamSources last checked: 2026-07-30Last updated: 2026-07-30Next planned review: 2028-07-29
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status — Source verified. This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.
General education. Low-risk educational or organizational content. Medical facts are cited to authoritative sources.
Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.
How this page was created
Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.
Editorial status: Source verified — This page was created with AI assistance and checked against the sources listed on it. Source checking is not a medical review.
Human medical review: not completed. Cancer Explained is not clinician-reviewed, and that is a deliberate design choice rather than a gap we are waiting to close. We restate published federal guidance and cite it; the authority belongs to the source, not to us. That is why every page names where its claims come from — so you can verify us instead of trusting us. Use it to understand your situation and to ask better questions of the people treating you.
Read more about our editorial process, our use of AI, and our corrections policy.
Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.
After using this page, do you understand what to do next?
Anonymous — we only record the answer, never who gave it.
Related articles
Still have questions?
Educational answers, plain language
Free to print and share